Back to EZorb Newsletter Index





In this issue:


1. Share Success: Letters From Readers
2. Research News: Low Bone Density Does Not Cause Musculoskeletal Pain
3. Useful Links
4. Calcium Absorption Test
5. What Are Others Saying About EZorb and Marvlix?

1. Share Success: Letters From Readers 


Letter I: From Denise

Received at Testimonial Submit Form on Saturday, September 13, 2014 at 10:41:18



My name is Denise.

I watched as a friend of mine took EZorb and Marvlix for his diabetes and arthritis. I have a rare disease that is called Porhyria in which my liver does not break down toxins.

Also am not able to eat much proteins and I am extremely sensitive to certain foods and chemicals such as perfume, air pollutants, etc.

After a month of taking Marvlix, my hospital stays became further and further apart. My reactions to many environmental stressors are less. Also, Asthma attacks are decreasing.

It has improved my daily life.

Letter II: From Anonymous

Received at Testimonial Submit Form on Wednesday, June 11, 2014 at 13:57:11



Hello, I had been relieved of bone (heel) spurs several years ago and continue to take EZorb. I would like to know if it can interfere in any way or put a burden on the liver.

A holistic doctor took me off of it temporarily while he is treating me to clear my liver of left over old bile. I have been doing well with his prescribed supplements to open up the bile ducts. (I had gotten rid of many gallstones already without surgery using liver flushes.) It seemed to me that since Ezorb is so well absorbed in the intestines that it shouldn't burden the liver. (Editor: of course NOT!)

Since being off it and taking only 450 mg of AlgaeCal a day, allowed by the doctor, I was starting to have bone and muscle pain after one month.

I have started back on EZorb @ 4 tsps a day as a test and after one week am feeling much better. Now I need to tell the doctor! Is Ezorb okay? Thank you for your time!

Letter III: From Sandra


Received at Testimonial Submit Form on Wednesday, May 28, 2014 at 11:17:24



Hi, my name is Sandra.

I have taken ezorb for a few years now, and bone density has increased immensely. No more osteoporosis. I am thrilled!

I ordered some Marvlix but have not taken it yet because I have questions about the other meds I'm on. I am on 3 heart medications and wonder if it's ok to take Marvlix too. I am on Carvedilol, Lisinopril, and spironolactone. I have COPD and am also on Spiriva, and Advair. I asked my Dr. about it but he sort of dismissed it with no real answer.

Thank you for your help!


From the Desk of EZorb Newsletter Editor:

This newsletter is now read by over 70,000 subscribers worldwide. Success stories you have contributed over the years have had a great impact on many people's quality of life. Your continuous support will be greatly appreciated by tens of thousands who have been suffering and would continuously suffer, without your help! Please email your story to or simply post it at Testimonial Submit Form. Your personal information will never be revealed to the public.

2. Research News: Low Bone Density Does Not Cause Musculoskeletal Pain


Bone mineral density (BMD) does not contribute to musculoskeletal pain, researchers report in findings that shed light on the controversy over whether osteoporosis is a painless disease.

The study showed that BMD, calculated from dual-energy X-ray absorptiometry scans, was not associated with the intensity or presence of back, knee or hip pain in 387 postmenopausal women from Korea, 21.3% of whom had osteoporosis in the femoral neck or lumbar spine.

The women were aged at least 50 years and had a low calcium intake and low serum levels of 25-hydroxyvitamin D compensated by elevated levels of alkaline phosphatase and parathyroid hormone.

"In light of the clinical uncertainty regarding whether osteoporosis is a painful disease, the results of this study could be interpreted as showing that osteoporosis itself does not cause musculoskeletal pain", write the study authors in Clinical Rheumatology.

They note, however, that some studies have shown significant correlations between improvements in lumbar pain and the percentage change in urinary N-telopeptide and increased BMD in bisphosphonate-treated patients.

This would suggest a possible link with the dynamic loss of BMD, measured using bone turnover markers, which were not assessed in the current study, rather than static BMD.

"Further study is needed to investigate this theory", researcher Sang Young Mood (Seoul National University, Kyungki, South Korea) and colleagues remark.

The women participating in the study had an average numeric rating scale pain score for hip and knee joints of 0.6 and 1.1, respectively. None of them were taking pain medication.

Multiple regression analysis showed that age was the only factor significantly correlated with hip pain intensity, adjusted for degree of osteoarthritis, while Kellgren–Lawrence grade of knee osteoarthritis was the only factor significantly associated with knee pain intensity.

Age was also the only factor significantly associated with the presence of back pain in binary logistic regression analysis.

"BMD did not contribute significantly to the intensity or presence of musculoskeletal pain in any body part analyzed", the team comments.

"Theoretically, osteoporosis could be a silent, painless disease defined by decreased BMD."

Original research was published in Clin Rheumatol 2014; Advance online publication.

3. Useful Links

Frequently Asked Questions & Answers

EZorb Clinical Studies

Marvlix Benefits

Order Now



4. Calcium Absorption Test

EZorb Calcium has set a new world record of absorption rate. You can compare EZorb with other calcium supplements by using the simple step-by-step instructions we provide. E-mail your request to for a copy of the instructions.



5. What Are Others Saying About EZorb and Marvlix?

EZorb and Marvlix have restored confidence in thousands of men and women. It has brought happiness and healthy life to families around the world. Click here to read what people say about EZorb and Marvlix.

Back to EZorb Newsletter Index

  Copyright 2014 Elixir Industry